MASHINIi

Opthea Limited.

OPT.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Opthea Limited is a biopharmaceutical company focused on developing and commercializing novel therapies for retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Their primary focus is on OPT-302, a soluble form of vascular endothelial growth fa...Show More

Ethical Profile

Mixed.

Opthea Limited, a clinical-stage biopharmaceutical company, is developing novel therapies for vision-threatening diseases like wet age-related macular degeneration (AMD) and diabetic macular edema (DME), with its lead product sozinibercept (OPT-302) in Phase 3 clinical trials. This core mission strongly aligns with "Better Health for All" by potentially offering new treatment options. However, its overall ethical profile is mixed. As a biopharmaceutical entity, Opthea likely relies on animal testing for drug development, a common industry practice, though specific animal welfare policies are not publicly detailed. Information is limited regarding fair pay, ethical sourcing, environmental impact, and community engagement. Future drug pricing could also create tension between profitability and patient accessibility.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-10
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Opthea Limited on Better Health for All.

Fair Money & Economic Opportunity

0

Opthea Limited is a biopharmaceutical company focused on developing and commercializing novel therapies for retinal diseases. The company's activities, as evidenced by the articles, revolve around securing financing for clinical trials and drug development. It does not operate as a financial institution, nor does it offer lending, deposit, or other financial services to consumers. Therefore, all KPIs related to fair money and economic opportunity, which assess financial institutions' practices, are not applicable to Opthea's business model.

Fair Pay & Worker Respect

0

No evidence available to assess Opthea Limited on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No evidence available to assess Opthea Limited on Fair Trade & Ethical Sourcing.

Honest & Fair Business

-10

Opthea Limited has not incurred any ethics-related regulatory fines in the past three years.

1
The company has a comprehensive whistleblower policy, approved in July 2019 and updated in February 2025, which applies to all directors, employees, and third parties.
2
It offers multiple reporting channels, including a third-party hotline, allows for anonymous reporting, and commits to protecting whistleblowers from retaliation.
3
The policy aims to conclude investigations within three months and is reviewed annually by the Audit & Risk Committee, with the Board informed of all material incidents.
4
The company has not had any financial restatements in the past five years.
5
As of September 28, 2023, 6 out of 8 directors were considered independent, representing 75% of the board.
6
Opthea also has an Anti-Bribery and Anti-Corruption Policy, approved on August 24, 2024, which adopts a zero-tolerance approach to bribery and corruption, prohibits facilitation payments, and requires annual review by the Audit and Risk Committee.
7
All workers are required to sign a certification confirming compliance with this policy, and awareness training is provided regularly.
8

Kind to Animals

0

No evidence available to assess Opthea Limited on Kind to Animals.

No War, No Weapons

0

Opthea Limited is a clinical-stage biopharmaceutical company focused on developing drugs for eye diseases. The company's operations are in the medical technology and healthcare sector, with no mention of defense-related activities.

1
There is no evidence to suggest that Opthea is involved in arms manufacturing, military contracts, or activities directly related to war or conflict.
2
,
3
,
4
,
5
Therefore, based on the available information, a neutral score is appropriate due to the lack of evidence indicating either alignment or misalignment with the 'No War, No Weapons' value. The company's business model is fundamentally neutral to this value.

Planet-Friendly Business

0

No specific data or metrics related to Opthea Limited's environmental performance, targets, or initiatives were found across any of the provided articles.

1
All articles explicitly stated that no relevant data was present. Therefore, no KPIs could be scored against the 'Planet-Friendly Business' value.

Respect for Cultures & Communities

0

No specific, concrete data points were found in the provided articles for any of the KPIs related to 'Respect for Cultures & Communities' for OPT.US. The articles primarily discuss clinical trials, financial information, and proxy voting records for other entities, and explicitly state the absence of information regarding cultural and community initiatives for OPT.US.

1

Safe & Smart Tech

0

The company's privacy policy states compliance with applicable laws and regulations, including GDPR.

1
It indicates that data is retained only as long as necessary for stated purposes.
2
Users are provided with options to opt-out of marketing communications and manage cookie preferences.
3

Zero Waste & Sustainable Products

0

No evidence available to assess Opthea Limited on Zero Waste & Sustainable Products.

Own Opthea Limited?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.